Healthcare Services

Global Allogeneic Cell Therapy Market Global Report 2026 Market Expected to Reach $1.97 Billion by 2030 with 10.2% CAGR

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Allogeneic Cell Therapy Market Projected To Become By 2030 Based On Its 2026 Valuation?

The allogeneic cell therapy market size has experienced rapid expansion in recent years. This market is projected to expand from $1.2 billion in 2025 to $1.34 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.5%. Historically, this growth can be attributed to factors such as the limited availability of allogeneic cell therapy products, the broadening of early-stage clinical trials, an escalating prevalence of hematological disorders, the increasing integration of cell therapies by hospitals, and a reliance on donor cell banks.

The allogeneic cell therapy market is poised for significant expansion in the coming years. This market is projected to reach $1.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. Several factors contribute to this projected growth, including progress in stem cell and immune cell engineering, a wider array of dermatological and other therapeutic applications, increased capital allocation for cell therapy production sites, partnerships between healthcare institutions and biotechnology companies, and the integration of automated cell processing technologies. Key trends anticipated during this period encompass the growing acceptance of stem cell therapies, heightened interest in T-cell and NK cell therapies, broadening of IPSC-based therapeutic uses, an increasing need for customized cell therapy solutions, and strengthened regulatory frameworks coupled with improved safety protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Allogeneic Cell Therapy Market?

The expanding occurrence of chronic illnesses is anticipated to propel the expansion of the allogeneic cell therapy market. A chronic illness refers to an enduring ailment often necessitating continuous medical care, potentially restricting everyday pursuits or overall well-being. The widespread nature of chronic conditions stems from changes in lifestyle, genetic predispositions, and encounters with chemicals, toxins, and atmospheric pollutants. Allogeneic cell therapy offers considerable promise in addressing numerous chronic diseases through the use of healthy donor cells to mend, substitute, or regulate impaired cells or tissues within the patient. For example, in January 2023, data from the National Center for Biotechnology Information (NCBI), a US-based medicine library, indicated that the population aged 50 and above grappling with at least one chronic ailment is projected to rise by 99.5% by 2050, surging from 71.52 million in 2020 to 142.66 million. Consequently, the heightened occurrence of chronic diseases is a key factor driving the expansion of the allogeneic cell therapy market.

What Segment Groups Are Identified Within The Allogeneic Cell Therapy Market?

The allogeneic cell therapy market covered in this report is segmented –

1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders

3) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy

2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies

What Trends Are Advancing Progress In The Allogeneic Cell Therapy Market?

Leading companies in the allogeneic cell therapy market are concentrating on developing innovative solutions, such as cell processing platforms, to strengthen their market position. Cell processing platforms are systems and technologies utilized to prepare and manipulate cells for therapeutic applications, covering isolation, purification, expansion, modification, and quality control to ensure cells are fit for clinical use. For instance, in March 2024, Getinge, a Sweden-based healthcare company, partnered with CellRev, a UK-based biotechnology company, to launch Livit ACE, a platform for continuous cell processing (Adherent Cell Expansion). This advanced platform integrates sophisticated automation and bioprocessing technologies, significantly improving the efficiency and scalability of cell production. Its distinctive features include cutting-edge cell isolation and purification systems that guarantee high cell purity and viability, robust expansion capabilities to produce substantial quantities of therapeutic cells, sophisticated genetic modification tools for precise cell engineering, and rigorous quality control measures to ensure the safety and efficacy of the cell products.

Which Companies Hold Significant Positions In The Allogeneic Cell Therapy Market?

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

Read the full allogeneic cell therapy market report here:

https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

Which Regions Are Projected To Dominate The Allogeneic Cell Therapy Market In The Coming Years?

North America was the largest region in the allogeneic cell therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allogeneic Cell Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15976&type=smp

Browse Through More Reports Similar to the Global Allogeneic Cell Therapy Market 2026, By The Business Research Company

Cells Therapy global market report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

autologous cell therapy global market report

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795